Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients

2014499 citationsJournal Articlebronze Open Access

Authors

Nassim Kamar · Université Toulouse III - Paul Sabatier

Jacques Izopet · Inserm

Simona Tripon · Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale

Michaël Bismuth · Hôpital Saint Eloi

Sophie Hillaire · Hôpital Foch

Jérôme Dumortier · Hôpital Edouard Herriot

Sylvie Radenne

Abstract

This retrospective, multicenter study showed that ribavirin as monotherapy may be effective in the treatment of chronic HEV infection; a 3-month course seemed to be an appropriate duration of therapy for most patients.

Topics & Keywords

Hepatitis Viruses Studies and Epidemiology Liver Disease and Transplantation Viral gastroenteritis research and epidemiology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 370, Issue 12, pp. 1111-1120

DOI: 10.1056/nejmoa1215246

Field-Weighted Citation Impact: 28.59